Condition
Celiac
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed2
Suspended1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07128966Recruiting
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
NCT04031469Suspended
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
NCT03122093Completed
Celiac Disease and Diabetes Longitudinal Follow-up and Evaluation Study
NCT04240340Completed
Experiences of Disclosure in Adolescents With Coeliac Disease
NCT03644069Phase 2Unknown
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)
Showing all 5 trials